V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005139 | 310002349 | 1.8 | 110 | Neo-adjuvant (N) | 2016-08-22 | 2016-08-23 | CAPECITABINE + CISPLATIN + Trastuzumab | 2 | N | 310000568 | PAZOPANIB |
| 310005140 | 310002349 | 1.65 | null | Curative (C) | 2018-09-10 | 2018-09-10 | LANREOTIDE | Y | N | 310000568 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005141 | 310002349 | 1.51 | 64 | Not known (9) | 2016-09-14 | 2016-09-30 | R GCVP | 02 | N | 310000568 | CARBOPLATIN + LIPOSOMAL DOX |
| 310005142 | 310002350 | 1.75 | null | Curative (C) | 2017-06-26 | 2017-06-28 | FEC | 02 | N | 310000732 | ICON8B TRIAL |
| 310005143 | 310002351 | null | 83.3 | Curative (C) | null | 2017-01-05 | INTERFERON | null | null | 310000733 | ECF |
| 310005144 | 310002352 | 1.68 | 62.2 | Palliative (P) | 2013-08-29 | 2013-09-12 | CARBOPLATIN + VINORELBINE | 02 | null | 310000744 | CVP R |
| 310005145 | 310002352 | 1.68 | 75 | Palliative (P) | 2017-04-20 | 2017-04-23 | Capecitabine + Cisplatin + RT | 02 | N | 310000744 | BEAM |
| 310005146 | 310002353 | 1.78 | 0 | Curative (C) | 2018-11-23 | 2018-12-01 | FEC | N | N | 310000823 | ICON8B TRIAL |
| 310005147 | 310002353 | 1.83 | 80.3 | Palliative (P) | 2017-06-26 | 2017-07-05 | Cetuximab + Radiotherapy Load | N | N | 310000823 | CAPECITABINE + CISPLATIN + RT |
| 310005148 | 310002354 | 1.68 | 65 | Palliative (P) | 2015-06-15 | 2016-10-22 | CARBOPLATIN + RT | N | N | 310000909 | CHLVPP |
| 310005149 | 310002355 | 1.83 | 77.5 | Palliative (P) | 2017-09-21 | 2017-09-22 | CAPECITABINE + CARBOPLATIN | N | N | 310000955 | CARBOPLATIN + VINORELBINE |
| 310005150 | 310002356 | null | 75.1 | Palliative (P) | 2014-01-16 | 2014-01-20 | NB BEACON Temozolomide Bevacizumab | N | N | 310001026 | CAPECITABINE + CISPLATIN + EPIRUBICIN |
| 310005151 | 310002356 | null | 67.7 | Curative (C) | 2015-07-03 | 2015-07-17 | ECHELON-2 TRIAL | 02 | N | 310001026 | DOXORUBICIN + IFOSFAMIDE |
| 310005152 | 310002357 | null | 91.4 | Curative (C) | null | 2016-07-08 | METHOTREXATE | N | null | 310001075 | BLEOMYCIN |
| 310005153 | 310002358 | 1.78 | null | null | null | 2018-05-07 | LENALIDOMIDE | null | N | 310001079 | CYTARABINE |
| 310005154 | 310002359 | 1.61 | 0 | Palliative (P) | 2016-04-15 | 2016-04-30 | ICON8B TRIAL | N | N | 310001118 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005155 | 310006980 | 1.72 | 73.1 | Palliative (P) | 2016-02-20 | 2016-03-01 | Irinotecan + Modified De Gramont | 2 | N | 310001136 | ESHAP |
| 310005156 | 310002360 | 1.76 | 0 | Disease modification (D) | 2013-02-14 | 2013-02-21 | Carboplatin + Vinorelbine IV | 02 | N | 310001147 | CAPECITABINE + CARBOPLATIN |
| 310005157 | 310002360 | 1.65 | 59 | Palliative (P) | 2017-12-10 | 2017-12-19 | FEC 60 or 75 | 02 | N | 310001147 | SUNITINIB |
| 310005158 | 310002360 | 1.82 | 0 | Curative (C) | 2017-10-19 | 2017-10-20 | CARBOPLATIN + RT | N | N | 310001147 | CAPECITABINE + CARBOPLATIN |
| 310005159 | 310002360 | 1.53 | 58.4 | null | 2014-10-08 | 2014-10-23 | EC | N | N | 310001147 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN |
| 310005160 | 310002360 | 1.58 | 66.2 | Disease modification (D) | 2015-06-15 | 2015-06-26 | CAPECITABINE + MITOMYCIN + RT | Y | N | 310001147 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005161 | 310002361 | null | 56 | Curative (C) | 2016-06-25 | 2016-06-27 | FEC 60 or 75 | 02 | N | 310001324 | CARBOPLATIN + PACLITAXEL + RT |
| 310005162 | 310002362 | null | 53.2 | Palliative (P) | 2017-07-04 | 2017-07-05 | Bevacizumab 15mg/kg | 2 | N | 310001330 | CARBOPLATIN + LIPOSOMAL DOX |
| 310005163 | 310002362 | 1.5 | 56.7 | Palliative (P) | 2016-09-18 | 2016-09-19 | Sunitinib | 02 | N | 310001330 | FEC + DOCETAXEL |
| 310005164 | 310002362 | 1.68 | 28.2 | Curative (C) | 2017-07-18 | 2017-07-18 | AXITINIB | N | N | 310001330 | METHOTREXATE HIGH DOSE |
| 310005165 | 310002362 | 1.63 | 67.6 | Disease modification (D) | 2018-05-05 | 2018-05-13 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 310001330 | SUNITINIB |
| 310005166 | 310002363 | 1.6 | 67.2 | Curative (C) | 2013-05-02 | 2015-02-16 | GC Int Guide Excranial GermCell JEB | null | N | 310001384 | FEC + DOCETAXEL |
| 310005167 | 310002364 | -1 | null | Curative (C) | 2014-11-28 | 2014-12-16 | DABRAFENIB | 2 | N | 310001389 | FLUOROURACIL |
| 310005168 | 310002365 | 1.58 | null | Palliative (P) | 2018-06-28 | 2018-07-13 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 310001395 | ICON8B TRIAL |
| 310005169 | 310002365 | 1.78 | null | Disease modification (D) | null | 2014-08-20 | CYCLOPHOSPHAMIDE | null | N | 310001395 | AZACITIDINE |
| 310005170 | 310002366 | 1.7 | 72.2 | Curative (C) | 2017-11-15 | 2017-11-29 | Cyclophosphamide High Dose | N | N | 310001439 | ESHAP |
| 310005171 | 310002367 | 1.62 | 0 | Curative (C) | 2013-04-14 | 2013-04-28 | Doxorubicin + Olaratumab | 02 | N | 310001451 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005172 | 310002367 | 1.81 | 93 | null | 2017-09-21 | 2017-10-05 | Doxorubicin + Ifosfamide | 02 | N | 310001451 | R CODOX M |
| 310005173 | 310002368 | 1.82 | 119.2 | Curative (C) | 2015-01-18 | 2015-01-18 | Carbo F | null | N | 310001526 | PAZOPANIB |
| 310005174 | 310002369 | 1.7 | 76 | Adjuvant (A) | 2015-12-12 | 2015-12-12 | Carboplatin + Pemetrexed | N | N | 310001592 | ECHELON-2 TRIAL |
| 310005175 | 310002370 | 1.95 | 0 | Palliative (P) | 2018-08-15 | 2018-08-22 | ESHAP | N | N | 310001608 | DABRAFENIB |
| 310005176 | 310002371 | 1.57 | 64.8 | Disease modification (D) | 2015-07-19 | 2015-07-19 | Mitotane 2.5g | N | null | 310001616 | EVEROLIMUS |
| 310005177 | 310002371 | 1.8 | 73.4 | Curative (C) | null | 2016-10-02 | BEP 5 Day | 02 | N | 310001616 | CISPLATIN + PEMETREXED |
| 310005178 | 310002372 | 1.53 | 67.8 | Curative (C) | 2015-10-09 | 2015-10-30 | DABRAFENIB | 2 | N | 310001625 | CVP R |
| 310005179 | 310002373 | 1.64 | null | Curative (C) | 2019-01-10 | 2019-01-12 | Cytarabine Low Dose | 02 | N | 310001636 | CYCLOPHOSPHAMIDE |
| 310005180 | 310002374 | 1.58 | 62.2 | Palliative (P) | 2017-01-31 | 2017-02-16 | FEC 60 or 75 | null | N | 310001682 | MITOMYCIN |
| 310005181 | 310002375 | 1.69 | 72.1 | Neo-adjuvant (N) | 2015-03-23 | 2015-03-23 | BEP 5 Day | 01 | N | 310001699 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005182 | 310002376 | null | 93.6 | Palliative (P) | 2013-12-26 | 2013-12-26 | EP | N | N | 310001718 | FLUOROURACIL |
| 310005183 | 310002376 | null | 59.3 | Palliative (P) | 2015-07-02 | 2015-07-05 | Sunitinib | N | N | 310001718 | THALIDOMIDE |
| 310005184 | 310002377 | null | 61.35 | Adjuvant (A) | null | 2013-10-09 | CARBOPLATIN + PACLITAXEL + RT | null | N | 310001772 | PLUTO TRIAL |
| 310005185 | 310002378 | null | 75.9 | Adjuvant (A) | 2014-11-23 | 2014-11-23 | Etoposide + Ifosfamide (3 days) | N | N | 310001788 | CISPLATIN + FLUOROURACIL + RT |
| 310005186 | 310002379 | null | null | Palliative (P) | 2015-09-18 | 2015-09-18 | CVP R + GEMCITABINE | 01 | N | 310001794 | LENALIDOMIDE |
| 310005187 | 310002380 | null | 64.4 | Curative (C) | null | 2018-07-11 | Chlorambucil | 2 | null | 310001860 | CARBO + FLUOROURACIL |
| 310005188 | 310006987 | null | 62.1 | Palliative (P) | 2013-04-05 | 2013-11-08 | DABRAFENIB | 02 | N | 310001938 | DOXORUBICIN + OLARATUMAB |